drug access

Views & Analysis

The impact of the debate on the Right-to-Try laws in the US and what needs to be done to improve access to innovative drugs.

Views & Analysis

Impact of putting access to medicine at the core of pharma businesses.

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.